APA (7th ed.) Citation

Gu, X., Shi, Z., Shao, L., Zhang, Y., Zhang, Y., Song, Z., . . . Lou, G. (2022). Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer. BMC Cancer, 22(1), 1. https://doi.org/10.1186/s12885-022-09674-2

Chicago Style (17th ed.) Citation

Gu, Xiaodong, Zhiyong Shi, Lan Shao, Yuxin Zhang, Yiping Zhang, Zhengbo Song, Wenxian Wang, and Guangyuan Lou. "Efficacy and Safety of Maintenance Immune Checkpoint Inhibitors with or Without Pemetrexed in Advanced Non-squamous Non-small Cell Lung Cancer." BMC Cancer 22, no. 1 (2022): 1. https://doi.org/10.1186/s12885-022-09674-2.

MLA (9th ed.) Citation

Gu, Xiaodong, et al. "Efficacy and Safety of Maintenance Immune Checkpoint Inhibitors with or Without Pemetrexed in Advanced Non-squamous Non-small Cell Lung Cancer." BMC Cancer, vol. 22, no. 1, 2022, p. 1, https://doi.org/10.1186/s12885-022-09674-2.